BMRN vs CPT · P/E 40, rev $1.76B vs P/E 104, rev $5.3M
Biomarin Pharmaceutical Inc (BMRN) versus Camden Property Trust (CPT) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CPT revenue for 2026-06-30 was $5.3M. Net income was $61.2M. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Not investment advice. Open the BMRN and CPT stock pages for the full models.
Not investment advice.